Channelrhodopsin variants engage distinct patterns of network activity

Citations Over Time

Abstract

Abstract Channelrhodopsins (ChRs) are light-gated ion channels that enable cell type-specific activation of neurons or neural circuits. Channelrhodopsin-2 has been widely used as a tool to probe circuit function in vitro and in vivo . Several recently developed ChR variants are characterized by faster kinetics and reduced desensitization. However, little is known about how their varying properties may regulate their interaction with local network dynamics. We compared ChR-evoked patterns of multi-unit activity and local field potentials in primary visual cortex of mice expressing three ChR variants with distinct temporal profiles: Chronos, Chrimson, and ChR2. We assessed overall activation of by measuring the amplitude and temporal progression of evoked spiking. Using gamma-range (30-80Hz) LFP power as an assay for local network engagement, we examined the recruitment of cortical network activity by each tool. All ChR variants caused light-evoked increases in firing in vivo , but each demonstrated different temporal patterning of evoked activity. In addition, the three ChRs had distinct effects on cortical gamma-band activity. Our findings suggest that variations in the kinetics of optogenetic tools can substantially affect their efficacy in neural networks in vivo , as well as the manner in which their activation engages circuit resonance.

Related Papers

• → On the photovoltaic effect in local field potential recordings(2016)38 cited
• → Optogenetic control of medaka behavior with channelrhodopsin(2023)7 cited
• In vivo activation of channelrhodopsin-2 used to determine the role of spontaneous neural activity in axonal guidance(2011)
• → Faculty Opinions recommendation of In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2.(2007)
• → Faculty Opinions recommendation of In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2.(2007)